We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Savient Pharmaceuticals Inc., a specialty pharmaceuticals company focused on developing, manufacturing and marketing novel therapeutic products for unmet medical needs, today announced the appointment of Brian J. Hayden as the Company's Senior Vice President, Chief Financial Officer & Treasurer effective immediately.
Cardinal Health, a leading provider of products and services supporting the health-care industry, on July 5 announced organizational changes to align its manufacturing businesses and sharpen its focus on expanding the market for its products and services outside the United States.
Barr Pharmaceuticals, Inc. today announced that the Company's Board of Directors unanimously reaffirmed its commitment to the official Croatian Financial Services Supervisory Agency (HANFA) takeover process for Zagreb, Croatia-based PLIVA d.d.
Pharmaceutical and medical devices company Abbott Laboratories on Thursday said it teamed with a unit of biotechnology company Fisher Scientific International Inc. to collaborate on drug discovery
using RNA interference, which prevents certain genes from expressing themselves.
Roche announced recently that it had ended a Phase III trial of Avastin's effectiveness in treating pancreatic cancer because an independent study showed that the drug did not improve patients' survival chances.
TeGenero, the German pharmaceutical startup whose UK-based clinical trial for its immune-boosting drug TGN1412 caused severe adverse reactions in six healthy male volunteers, has announced that it filed for bankruptcy protection in a court in Wurzburg, Germany, on July 4.
Anika Therapeutics, Inc. today announced that it has signed an exclusive worldwide development and commercialization agreement with Galderma Pharma S.A., a joint venture between Nestle and L'Oreal, for cosmetic tissue augmentation ("CTA") therapies.